Physician profile
William S Sawchuk
NPI 1205954542
$36,153.66
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $7,242 · 2021: $4,767 · 2022: $350.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $17,669.44 | 2019-2020 | |
| Abbvie INC. | $17,255.16 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $161.14 | 2019 | |
| Epi Health, LLC | $159.99 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $147.66 | 2019 | |
| Incyte Corporation | $139.32 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $118.20 | 2022 | |
| Janssen Scientific Affairs, LLC | $103.92 | 2019 | |
| Ucb, INC. | $81.27 | 2019-2022 | |
| Celgene Corporation | $58.03 | 2019 | |
| Janssen Biotech, INC. | $54.88 | 2019 | |
| Amgen INC. | $52.56 | 2020 | |
| Novartis Pharmaceuticals Corporation | $24.70 | 2019 | |
| Genzyme Corporation | $23.24 | 2022 | |
| Almirall LLC | $19.81 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $18.77 | 2022 | |
| Mayne Pharma Commercial LLC | $18.49 | 2019 | |
| Vyne Pharmaceuticals INC. | $17.12 | 2020 | |
| Sanofi-Aventis U.S. LLC | $15.00 | 2021 | |
| Leo Pharma INC. | $14.96 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sawchuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.